Navigation Links
Iowa State researchers develop technology for early detection of viruses
Date:10/30/2007

AMES, Iowa -- Iowa State University researchers have developed a technology that detects a single molecule of the virus associated with cervical cancer in women.

Thats a significant improvement over the current test for the human papillomavirus, said Edward Yeung, an Iowa State Distinguished Professor and the Robert Allen Wright Chair in Chemistry who led the research team that developed the new test. The current test, the Nobel Prize-winning polymerase chain reaction technique, requires 10 to 50 virus molecules for detection.

We are always interested in detecting smaller and smaller amounts of material at lower and lower concentrations, Yeung said. Detecting lower levels means earlier diagnosis.

The discovery by Yeung, whos also a senior chemist and deputy program director for the U.S. Department of Energys Ames Laboratory at Iowa State; Jiangwei Li, an Iowa State doctoral student; and Ji-Young Lee, a former Iowa State doctoral student; will be published in the Nov. 1 issue of the journal Analytical Chemistry.

Their work was funded by a five-year, $950,000 grant from the National Institutes of Health with additional support from The Robert Allen Wright Endowment for Excellence at Iowa State.

The project advanced just as human papillomavirus made national headlines. In June of 2006, the U.S. Food and Drug Administration approved a vaccine developed to prevent cervical cancer, precancerous lesions and genital warts caused by four types of the virus. The vaccine has been approved for females ages 9 to 26.

The Centers for Disease Control and Prevention reports the human papillomavirus is the most common sexually transmitted infection in the U.S. The agency estimates about 6.2 million Americans are infected every year and over half of all sexually active Americans are infected at some time in their lives.

Yeung said single molecule detection of the virus could help women and families decide to get
'/>"/>

Contact: Edward Yeung
yeung@ameslab.gov
515-294-8062
Iowa State University  
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. NC State scientist finds soft tissue in T. rex bones
5. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
6. Test for early detection of prostate cancer shows promise
7. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
8. Disease diagnosis, bioengineering covered at state nano summit
9. U-M researchers identify new blood test for prostate cancer
10. U-M scientists say fused genes trigger the development of prostate cancer
11. K-State professors discover enzyme responsible for creation of a beetles hard shell

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iowa State researchers develop technology for early detection of viruses
Iowa State researchers develop technology for early detection of viruses
(Date:11/25/2009)... Sarit Larisch, Head of the Cell Death Research La...f Biology, has been awarded the prestigious Johnso... exploring the cause of brain cell damage in Parki...ear to scientists in support of innovation and exc...icially conferred earlier this month at an event a...
(Date:11/24/2009)...housands of years it has been prescribed by tradit...ts from headaches and stomach pain to fever and fl...stle University have been able to scientifically p...ata otherwise known as Brazilian mint. , Testin...am led by researcher Graciela Rocha was able to sh...
(Date:11/24/2009)...tomic-level action of a remarkable class of ring-s...hers with the Lawrence Berkeley National Laborator...crystallography beamline at the Advanced Light Sou... in gene expression and replication, and are vital...as infectious agents, such as the human papillomav...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4A Safety Slip 3A Dont Hold a Child in Your Lap on Playground Slides 56173 1A Safety Slip 3A Dont Hold a Child in Your Lap on Playground Slides 56173 2Americas No 1 Pharmacy Names Great Health as Its Exclusive Health and Wellness Magazine 56168 1Rodgers Introduces SamarionSolution to International Audience 56164 1Rodgers Introduces SamarionSolution to International Audience 56164 2
...ational group of researchers today unveiled a deta...or histocompatibility complex (MHC), the most impo...n response to infection, autoimmune disease and or...ne in the analysis of genetic variability for this... foundation for future efforts aimed at uncovering...
...,s most widely used organic insecticide, a plucky ...r short, requires the assistance of other microbes...as found. , Writing in the Sept. 26 issue of the ...NAS), a team of researchers from the University of...f the native bacteria that colonize the insect gut...
...rs have achieved an effective immune response to a...-quarter of the norm when they added a chemical mi...the November 1 issue of Clinical Infectious Diseas...--a substance that increases the immune system,s a..., the investigators used inactivated H9N2 influenz...
Other Biology News:International team analyzes human genetic variation in key immune region 2International team analyzes human genetic variation in key immune region 3Most widely used organic pesticide requires help to kill 2Most widely used organic pesticide requires help to kill 3
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PRNe...: DCGN ) today announced that it has received noti...e company,s common stock will be,suspended as of N...ith the,Securities and Exchange Commission, which ...Nasdaq, unless the company files an appeal to the ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PRNe...: DCGN ) today announced the approval of all of it... for the District of Delaware,(the "Bankruptcy Cou...for,relief under Chapter 11 of the United States B... The orders issued by the Bankruptcy Court allow...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shangh...Drug Administration (SFDA) has approved the,invest...insulin project,(Nodlin), an innovative insulin fo...ows Biolaxy to initiate its first phase I clinical...ristic of high blood glucose and poor,metabolism. ...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
... , Shareholders are Urged to Vote their YELLOW ...d and Independent Directors to the Biovail Board, ...Shareholders of Biovail today said that Biovail Co...lead its shareholders by making the focal point of...mply about governance reform and has already been ...
... Results from Phase 2 Clinical Trials of Carfilzom...anced Solid Tumors Featured in Oral Presentations ...today announced that data from clinical trials of ... tumors will be presented at the 2009 Annual Meeti...SCO) being held May 29 - June 2, 2009 in Orlando, ...
... LA JOLLA, Calif., May 15 Fate Therapeutics, In...e intellectual property rights jointly owned by Ch... Hospital. This intellectual property covers comp...stem cells. These proprietary technologies develo...l Program at Children,s Hospital Boston and a scie...
Other Biology Technology:The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 2The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 3The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 4The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 5The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 6The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders 7Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting 2Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting 3Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital 2Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital 3
Adaptor Hind III - Sma I from Takara Mirus Bio
DryStrip aligners from GE Healthcare, formerly Amersham Biosciences
Normal Calf Serum from Equitech-Bio
... at the 3, 3', 4, and 4' positions. It is intended...ation of PGE1 by GC- or LC-mass spectrometry. PGE1...ihomo-γ-linolenic acid (DGLA), but it is vi...s or other animals. Its pharmacology includes vaso...
Biology Products: